Cargando…
The effect of 5‐HT(1A) receptor agonists on the entopeduncular nucleus is modified in 6‐hydroxydopamine‐lesioned rats
BACKGROUND AND PURPOSE: l‐DOPA prolonged treatment leads to disabling motor complications as dyskinesia that could be decreased by drugs acting on 5‐HT(1A) receptors. Since the internal segment of the globus pallidus, homologous to the entopeduncular nucleus in rodents, seems to be involved in the e...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252460/ https://www.ncbi.nlm.nih.gov/pubmed/33686657 http://dx.doi.org/10.1111/bph.15437 |
_version_ | 1783717305577897984 |
---|---|
author | Vegas‐Suárez, Sergio Aristieta, Asier Requejo, Catalina Bengoetxea, Harkaitz Lafuente, José Vicente Miguelez, Cristina Ugedo, Luisa |
author_facet | Vegas‐Suárez, Sergio Aristieta, Asier Requejo, Catalina Bengoetxea, Harkaitz Lafuente, José Vicente Miguelez, Cristina Ugedo, Luisa |
author_sort | Vegas‐Suárez, Sergio |
collection | PubMed |
description | BACKGROUND AND PURPOSE: l‐DOPA prolonged treatment leads to disabling motor complications as dyskinesia that could be decreased by drugs acting on 5‐HT(1A) receptors. Since the internal segment of the globus pallidus, homologous to the entopeduncular nucleus in rodents, seems to be involved in the etiopathology of l‐DOPA‐induced dyskinesia, we investigated whether the entopeduncular nucleus is modulated by the 5‐HT(1A) receptor partial and full agonists, buspirone, and 8‐hydroxy‐2‐(di‐n‐propylamino)‐tetralin (8‐OH‐DPAT) in control and 6‐hydroxydopamine (6‐OHDA)‐lesioned rats with or without long‐term l‐DOPA treatment. EXPERIMENTAL APPROACH: Extracellular single‐unit electrocorticogram and local field potential recordings under anaesthesia, immunostaining assays and optogenetic manipulation coupled to electrophysiological recordings were performed. KEY RESULTS: Systemic buspirone reduced the entopeduncular nucleus firing rate in the sham animals and burst activity in the 6‐OHDA‐lesioned rats (with or without l‐DOPA treatment), while local administration reduced entopeduncular nucleus activity in all the groups, regardless of DA integrity. Systemic 8‐OH‐DPAT also induced inhibitory effects only in the sham animals. Effects triggered by buspirone and 8‐OH‐DPAT were reversed by the 5‐HT(1A) receptor antagonist, WAY‐100635. Neither buspirone nor 8‐OH‐DPAT modified the low‐frequency oscillatory activity in the entopeduncular nucleus or its synchronization with the motor cortex. Buspirone did not alter the response induced by subthalamic nucleus opto‐stimulation in the entopeduncular nucleus. CONCLUSION AND IMPLICATIONS: Systemic 5‐HT(1A) receptor activation elicits different effects on the electrophysiological properties of the entopeduncular nucleus depending on the integrity of the nigrostriatal pathway and it does not alter the relationship between subthalamic nucleus and entopeduncular nucleus neuron activity. |
format | Online Article Text |
id | pubmed-8252460 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-82524602021-07-07 The effect of 5‐HT(1A) receptor agonists on the entopeduncular nucleus is modified in 6‐hydroxydopamine‐lesioned rats Vegas‐Suárez, Sergio Aristieta, Asier Requejo, Catalina Bengoetxea, Harkaitz Lafuente, José Vicente Miguelez, Cristina Ugedo, Luisa Br J Pharmacol Research Papers BACKGROUND AND PURPOSE: l‐DOPA prolonged treatment leads to disabling motor complications as dyskinesia that could be decreased by drugs acting on 5‐HT(1A) receptors. Since the internal segment of the globus pallidus, homologous to the entopeduncular nucleus in rodents, seems to be involved in the etiopathology of l‐DOPA‐induced dyskinesia, we investigated whether the entopeduncular nucleus is modulated by the 5‐HT(1A) receptor partial and full agonists, buspirone, and 8‐hydroxy‐2‐(di‐n‐propylamino)‐tetralin (8‐OH‐DPAT) in control and 6‐hydroxydopamine (6‐OHDA)‐lesioned rats with or without long‐term l‐DOPA treatment. EXPERIMENTAL APPROACH: Extracellular single‐unit electrocorticogram and local field potential recordings under anaesthesia, immunostaining assays and optogenetic manipulation coupled to electrophysiological recordings were performed. KEY RESULTS: Systemic buspirone reduced the entopeduncular nucleus firing rate in the sham animals and burst activity in the 6‐OHDA‐lesioned rats (with or without l‐DOPA treatment), while local administration reduced entopeduncular nucleus activity in all the groups, regardless of DA integrity. Systemic 8‐OH‐DPAT also induced inhibitory effects only in the sham animals. Effects triggered by buspirone and 8‐OH‐DPAT were reversed by the 5‐HT(1A) receptor antagonist, WAY‐100635. Neither buspirone nor 8‐OH‐DPAT modified the low‐frequency oscillatory activity in the entopeduncular nucleus or its synchronization with the motor cortex. Buspirone did not alter the response induced by subthalamic nucleus opto‐stimulation in the entopeduncular nucleus. CONCLUSION AND IMPLICATIONS: Systemic 5‐HT(1A) receptor activation elicits different effects on the electrophysiological properties of the entopeduncular nucleus depending on the integrity of the nigrostriatal pathway and it does not alter the relationship between subthalamic nucleus and entopeduncular nucleus neuron activity. John Wiley and Sons Inc. 2021-05-06 2021-06 /pmc/articles/PMC8252460/ /pubmed/33686657 http://dx.doi.org/10.1111/bph.15437 Text en © 2021 The Authors. British Journal of Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Papers Vegas‐Suárez, Sergio Aristieta, Asier Requejo, Catalina Bengoetxea, Harkaitz Lafuente, José Vicente Miguelez, Cristina Ugedo, Luisa The effect of 5‐HT(1A) receptor agonists on the entopeduncular nucleus is modified in 6‐hydroxydopamine‐lesioned rats |
title | The effect of 5‐HT(1A) receptor agonists on the entopeduncular nucleus is modified in 6‐hydroxydopamine‐lesioned rats |
title_full | The effect of 5‐HT(1A) receptor agonists on the entopeduncular nucleus is modified in 6‐hydroxydopamine‐lesioned rats |
title_fullStr | The effect of 5‐HT(1A) receptor agonists on the entopeduncular nucleus is modified in 6‐hydroxydopamine‐lesioned rats |
title_full_unstemmed | The effect of 5‐HT(1A) receptor agonists on the entopeduncular nucleus is modified in 6‐hydroxydopamine‐lesioned rats |
title_short | The effect of 5‐HT(1A) receptor agonists on the entopeduncular nucleus is modified in 6‐hydroxydopamine‐lesioned rats |
title_sort | effect of 5‐ht(1a) receptor agonists on the entopeduncular nucleus is modified in 6‐hydroxydopamine‐lesioned rats |
topic | Research Papers |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252460/ https://www.ncbi.nlm.nih.gov/pubmed/33686657 http://dx.doi.org/10.1111/bph.15437 |
work_keys_str_mv | AT vegassuarezsergio theeffectof5ht1areceptoragonistsontheentopeduncularnucleusismodifiedin6hydroxydopaminelesionedrats AT aristietaasier theeffectof5ht1areceptoragonistsontheentopeduncularnucleusismodifiedin6hydroxydopaminelesionedrats AT requejocatalina theeffectof5ht1areceptoragonistsontheentopeduncularnucleusismodifiedin6hydroxydopaminelesionedrats AT bengoetxeaharkaitz theeffectof5ht1areceptoragonistsontheentopeduncularnucleusismodifiedin6hydroxydopaminelesionedrats AT lafuentejosevicente theeffectof5ht1areceptoragonistsontheentopeduncularnucleusismodifiedin6hydroxydopaminelesionedrats AT miguelezcristina theeffectof5ht1areceptoragonistsontheentopeduncularnucleusismodifiedin6hydroxydopaminelesionedrats AT ugedoluisa theeffectof5ht1areceptoragonistsontheentopeduncularnucleusismodifiedin6hydroxydopaminelesionedrats AT vegassuarezsergio effectof5ht1areceptoragonistsontheentopeduncularnucleusismodifiedin6hydroxydopaminelesionedrats AT aristietaasier effectof5ht1areceptoragonistsontheentopeduncularnucleusismodifiedin6hydroxydopaminelesionedrats AT requejocatalina effectof5ht1areceptoragonistsontheentopeduncularnucleusismodifiedin6hydroxydopaminelesionedrats AT bengoetxeaharkaitz effectof5ht1areceptoragonistsontheentopeduncularnucleusismodifiedin6hydroxydopaminelesionedrats AT lafuentejosevicente effectof5ht1areceptoragonistsontheentopeduncularnucleusismodifiedin6hydroxydopaminelesionedrats AT miguelezcristina effectof5ht1areceptoragonistsontheentopeduncularnucleusismodifiedin6hydroxydopaminelesionedrats AT ugedoluisa effectof5ht1areceptoragonistsontheentopeduncularnucleusismodifiedin6hydroxydopaminelesionedrats |